您的位置: 首页 > 农业专利 > 详情页

מיטוריבוסקינים: טיפולים המבוססים על מיטוכונדריות המכוונים מטרה לתאי סרטן, חיידקים, ושמרים פתוגניים
专利权人:
LUNELLA BIOTECH INC.;Michael P. LISANTI;Federica SOTGIA
发明人:
Michael P. LISANTI,Federica SOTGIA
申请号:
IL26930919
公开号:
IL269309D0
申请日:
2019.09.12
申请国别(地区):
IL
年份:
2019
代理人:
摘要:
The present disclosure relates to inhibitors of mitochondrial function. Methods of screening compounds for mitochondrial inhibition are disclosed. Also described are methods of using mitochondrial inhibitors called mitoriboscins—mitochondrial-based therapeutic compounds having anti-cancer and antibiotic properties—to prevent or treat cancer, bacterial infections, and pathogenic yeast, as well as methods of using mitochondrial inhibitors to provide anti-aging benefits. Specific mitoriboscin compounds and groups of mitoriboscins are also disclosed.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充